ArticleCancers2020

Baseline Splenic Volume as a Prognostic Biomarker of FOLFIRI Efficacy and a Surrogate Marker of MDSC Accumulation in Metastatic Colorectal Carcinoma.

Julie Niogret et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.